1	A	A	B-NP	DT	O	6	NMOD
2	low	low	I-NP	JJ	O	6	NMOD
3	complexity	complexity	I-NP	NN	O	6	NMOD
4	rapid	rapid	I-NP	JJ	O	6	NMOD
5	molecular	molecular	I-NP	JJ	O	6	NMOD
6	method	method	I-NP	NN	O	0	ROOT
7	for	for	B-PP	IN	O	6	NMOD
8	detection	detection	B-NP	NN	O	7	PMOD
9	of	of	B-PP	IN	O	8	NMOD
10	Clostridium	Clostridium	B-NP	NN	O	11	NMOD
11	difficile	difficile	I-NP	NN	O	9	PMOD
12	in	in	B-PP	IN	O	11	NMOD
13	stool	stool	B-NP	NN	O	12	PMOD
14	.	.	O	.	O	6	P

1	Here	Here	B-ADVP	RB	O	3	VMOD
2	we	we	B-NP	PRP	O	3	SUB
3	describe	describe	B-VP	VBP	O	0	ROOT
4	a	a	B-NP	DT	O	5	NMOD
5	method	method	I-NP	NN	O	3	OBJ
6	for	for	B-PP	IN	O	5	NMOD
7	the	the	B-NP	DT	O	8	NMOD
8	detection	detection	I-NP	NN	O	6	PMOD
9	of	of	B-PP	IN	O	8	NMOD
10	Clostridium	Clostridium	B-NP	NN	O	11	NMOD
11	difficile	difficile	I-NP	NN	O	9	PMOD
12	from	from	B-PP	IN	O	11	NMOD
13	stool	stool	B-NP	NN	O	12	PMOD
14	using	use	B-VP	VBG	O	3	VMOD
15	a	a	B-NP	DT	O	17	NMOD
16	novel	novel	I-NP	JJ	O	17	NMOD
17	low-complexity	low-complexity	I-NP	NN	O	21	NMOD
18	and	and	O	CC	O	21	NMOD
19	rapid	rapid	B-NP	JJ	O	21	NMOD
20	extraction	extraction	I-NP	NN	O	21	NMOD
21	process	process	I-NP	NN	O	14	OBJ
22	called	call	B-VP	VBN	O	21	NMOD
23	Heat	Heat	B-NP	NN	O	24	NMOD
24	Elution	Elution	I-NP	NN	O	22	VMOD
25	(	(	O	(	O	27	DEP
26	HE	HE	B-NP	NN	O	27	DEP
27	)	)	O	)	O	24	NMOD
28	.	.	O	.	O	3	P

1	The	The	B-NP	DT	O	3	NMOD
2	HE	HE	I-NP	NN	O	3	NMOD
3	method	method	I-NP	NN	O	4	SUB
4	is	be	B-VP	VBZ	O	15	VMOD
5	two-step	two-step	B-ADJP	JJ	O	4	PRD
6	and	and	O	CC	O	4	VMOD
7	takes	take	B-VP	VBZ	O	4	VMOD
8	just	just	B-NP	RB	O	10	NMOD
9	10	10	I-NP	CD	O	8	AMOD
10	minutes	minute	I-NP	NNS	O	7	OBJ
11	,	,	O	,	O	4	P
12	no	no	B-NP	DT	O	14	NMOD
13	specialist	specialist	I-NP	NN	O	14	NMOD
14	instruments	instrument	I-NP	NNS	O	15	SUB
15	are	be	B-VP	VBP	O	19	VMOD
16	required	require	I-VP	VBN	O	15	VC
17	and	and	O	CC	O	19	VMOD
18	there	there	B-NP	EX	O	19	SUB
19	is	be	B-VP	VBZ	O	0	ROOT
20	minimal	minimal	B-NP	JJ	O	22	NMOD
21	hands-on	hands-on	I-NP	JJ	O	22	NMOD
22	time	time	I-NP	NN	O	19	PRD
23	.	.	O	.	O	19	P

1	A	A	B-NP	DT	O	3	NMOD
2	test	test	I-NP	NN	O	3	NMOD
3	method	method	I-NP	NN	O	6	SUB
4	using	use	B-VP	VBG	O	3	NMOD
5	HE	HE	B-NP	NN	O	4	OBJ
6	was	be	B-VP	VBD	O	0	ROOT
7	developed	develop	I-VP	VBN	O	6	VC
8	in	in	B-PP	IN	O	7	VMOD
9	conjunction	conjunction	B-NP	NN	O	8	PMOD
10	with	with	B-PP	IN	O	9	NMOD
11	Loop-mediated	Loop-mediated	B-NP	JJ	O	13	NMOD
12	Isothermal	Isothermal	I-NP	JJ	O	13	NMOD
13	Amplification	Amplification	I-NP	NN	O	10	PMOD
14	(	(	O	(	O	16	DEP
15	LAMP	LAMP	B-NP	NN	O	16	DEP
16	)	)	O	)	O	13	NMOD
17	combined	combine	B-VP	VBN	O	13	NMOD
18	with	with	B-PP	IN	O	17	VMOD
19	the	the	B-NP	DT	O	23	NMOD
20	real-time	real-time	I-NP	JJ	O	23	NMOD
21	bioluminescent	bioluminescent	I-NP	JJ	O	23	NMOD
22	reporter	reporter	I-NP	NN	O	23	NMOD
23	system	system	I-NP	NN	O	18	PMOD
24	known	know	B-VP	VBN	O	23	NMOD
25	as	as	B-PP	IN	O	24	VMOD
26	BART	BART	B-NP	NNP	O	25	PMOD
27	targeting	target	B-VP	VBG	O	26	NMOD
28	the	the	B-NP	DT	O	31	NMOD
29	toxin	toxin	I-NP	NN	B-DNA	31	NMOD
30	B	B	I-NP	NN	I-DNA	31	NMOD
31	gene	gene	I-NP	NN	I-DNA	27	OBJ
32	(	(	O	(	O	34	DEP
33	tcdB	tcdB	B-NP	NN	B-DNA	34	DEP
34	)	)	O	)	O	31	NMOD
35	.	.	O	.	O	6	P

1	The	The	B-NP	DT	O	3	NMOD
2	HE-LAMP-BART	HE-LAMP-BART	I-NP	NN	O	3	NMOD
3	method	method	I-NP	NN	O	4	SUB
4	was	be	B-VP	VBD	O	0	ROOT
5	evaluated	evaluate	I-VP	VBN	O	4	VC
6	in	in	B-PP	IN	O	5	VMOD
7	a	a	B-NP	DT	O	9	NMOD
8	pilot	pilot	I-NP	NN	O	9	NMOD
9	study	study	I-NP	NN	O	6	PMOD
10	on	on	B-PP	IN	O	9	NMOD
11	clinical	clinical	B-NP	JJ	O	13	NMOD
12	fecal	fecal	I-NP	JJ	O	13	NMOD
13	samples	sample	I-NP	NNS	O	10	PMOD
14	(	(	O	(	O	28	DEP
15	tcdB	tcdB	B-NP	NN	O	20	NMOD
16	(	(	O	(	O	18	DEP
17	+	+	B-NP	SYM	O	18	DEP
18	)	)	O	)	O	15	NMOD
19	,	,	O	,	O	20	P
20	n = 111	n = 111	B-NP	NN	B-protein	27	NMOD
21	;	;	O	:	O	27	P
22	tcdB	tcdB	B-NP	NN	O	27	NMOD
23	(	(	O	(	O	25	DEP
24	-	-	B-NP	SYM	O	25	DEP
25	)	)	O	)	O	22	NMOD
26	,	,	O	,	O	27	P
27	n= 107	n= 107	B-NP	NN	B-protein	28	DEP
28	)	)	O	)	O	13	NMOD
29	.	.	O	.	O	4	P

1	The	The	B-NP	DT	O	3	NMOD
2	HE-LAMP-BART	HE-LAMP-BART	I-NP	NN	O	3	NMOD
3	method	method	I-NP	NN	O	4	SUB
4	showed	show	B-VP	VBD	O	0	ROOT
5	95.5	95.5	B-NP	CD	O	7	NMOD
6	%	%	I-NP	NN	O	7	NMOD
7	sensitivity	sensitivity	I-NP	NN	O	11	NMOD
8	and	and	O	CC	O	11	NMOD
9	100	100	B-NP	CD	O	10	AMOD
10	%	%	I-NP	NN	O	11	NMOD
11	specificity	specificity	I-NP	NN	O	4	OBJ
12	against	against	B-PP	IN	O	11	NMOD
13	a	a	B-NP	DT	O	17	NMOD
14	gold	gold	I-NP	JJ	O	17	NMOD
15	standard	standard	I-NP	JJ	O	17	NMOD
16	reference	reference	I-NP	NN	O	17	NMOD
17	method	method	I-NP	NN	O	12	PMOD
18	using	use	B-VP	VBG	O	4	VMOD
19	cytotoxigenic	cytotoxigenic	B-NP	JJ	O	20	NMOD
20	culture	culture	I-NP	NN	O	18	OBJ
21	and	and	O	CC	O	26	NMOD
22	also	also	B-ADVP	RB	O	26	NMOD
23	a	a	B-NP	DT	O	26	NMOD
24	silica-based	silica-based	I-NP	JJ	O	26	NMOD
25	robotic	robotic	I-NP	JJ	O	26	NMOD
26	extraction	extraction	I-NP	NN	O	18	OBJ
27	followed	follow	B-VP	VBN	O	26	NMOD
28	by	by	B-PP	IN	O	27	VMOD
29	tcdB	tcdB	B-NP	NN	O	30	NMOD
30	PCR	PCR	I-NP	NN	O	28	PMOD
31	to	to	B-VP	TO	O	32	VMOD
32	control	control	I-VP	VB	O	30	NMOD
33	for	for	B-PP	IN	O	32	VMOD
34	storage	storage	B-NP	NN	O	33	PMOD
35	.	.	O	.	O	4	P

1	From	From	B-PP	IN	O	10	VMOD
2	sample	sample	B-NP	NN	O	1	PMOD
3	to	to	B-VP	TO	O	4	VMOD
4	result	result	I-VP	VB	O	1	SBAR
5	,	,	O	,	O	10	P
6	the	the	B-NP	DT	O	8	NMOD
7	HE-LAMP-BART	HE-LAMP-BART	I-NP	NN	O	8	NMOD
8	method	method	I-NP	NN	O	10	SUB
9	typically	typically	B-ADVP	RB	O	10	VMOD
10	took	take	B-VP	VBD	O	0	ROOT
11	50	50	B-NP	CD	O	12	NMOD
12	minutes	minute	I-NP	NNS	O	10	OBJ
13	,	,	O	,	O	10	P
14	whereas	whereas	O	IN	O	10	VMOD
15	the	the	B-NP	DT	O	17	NMOD
16	PCR	PCR	I-NP	NN	O	17	NMOD
17	method	method	I-NP	NN	O	18	SUB
18	took	take	B-VP	VBD	O	14	SBAR
19	>	>	B-NP	SYM	O	21	NMOD
20	2.5	2.5	B-NP	CD	O	21	NMOD
21	hours	hour	I-NP	NNS	O	18	OBJ
22	.	.	O	.	O	10	P

1	In	In	B-PP	IN	O	21	VMOD
2	a	a	B-NP	DT	O	4	NMOD
3	further	further	I-NP	JJ	O	4	NMOD
4	study	study	I-NP	NN	O	1	PMOD
5	(	(	O	(	O	19	DEP
6	tcdB	tcdB	B-NP	NN	O	11	NMOD
7	(	(	O	(	O	9	DEP
8	+	+	B-NP	SYM	O	9	DEP
9	)	)	O	)	O	6	NMOD
10	,	,	O	,	O	11	P
11	n = 47	n = 47	B-NP	NN	B-protein	18	NMOD
12	;	;	O	:	O	18	P
13	tcdB	tcdB	B-NP	NN	O	18	NMOD
14	(	(	O	(	O	16	DEP
15	-	-	B-NP	SYM	O	16	DEP
16	)	)	O	)	O	13	NMOD
17	,	,	O	,	O	18	P
18	n= 28	n= 28	B-NP	NN	O	19	DEP
19	)	)	O	)	O	4	NMOD
20	HE-LAMP-BART	HE-LAMP-BART	B-NP	NN	O	21	SUB
21	was	be	B-VP	VBD	O	0	ROOT
22	compared	compare	I-VP	VBN	O	21	VC
23	to	to	B-PP	TO	O	22	VMOD
24	an	an	B-NP	DT	O	25	NMOD
25	alternative	alternative	I-NP	NN	O	27	AMOD
26	commercially	commercially	B-NP	RB	O	27	AMOD
27	available	available	I-NP	JJ	O	29	NMOD
28	LAMP-based	LAMP-based	I-NP	JJ	O	29	NMOD
29	method	method	I-NP	NN	O	31	NMOD
30	,	,	O	,	O	31	P
31	Illumigene	Illumigene	B-NP	NN	B-DNA	23	PMOD
32	(	(	O	(	O	37	DEP
33	Meridian	Meridian	B-NP	NNP	O	34	NMOD
34	Bioscience	Bioscience	I-NP	NNP	O	37	DEP
35	,	,	O	,	O	37	P
36	OH	OH	B-NP	NN	O	37	DEP
37	)	)	O	)	O	31	NMOD
38	,	,	O	,	O	21	P
39	and	and	O	CC	O	21	VMOD
40	yielded	yield	B-VP	VBD	O	21	VMOD
41	87.2	87.2	B-NP	CD	O	43	NMOD
42	%	%	I-NP	NN	O	43	NMOD
43	sensitivity	sensitivity	I-NP	NN	O	47	NMOD
44	and	and	O	CC	O	47	NMOD
45	100	100	B-NP	CD	O	46	AMOD
46	%	%	I-NP	NN	O	47	NMOD
47	specificity	specificity	I-NP	NN	O	40	OBJ
48	for	for	B-PP	IN	O	47	NMOD
49	the	the	B-NP	DT	O	51	NMOD
50	HE-LAMP-BART	HE-LAMP-BART	I-NP	NN	O	51	NMOD
51	method	method	I-NP	NN	O	48	PMOD
52	compared	compare	B-VP	VBN	O	47	NMOD
53	to	to	B-PP	TO	O	52	VMOD
54	76.6	76.6	B-NP	CD	O	55	NMOD
55	%	%	I-NP	NN	O	58	NMOD
56	and	and	O	CC	O	58	NMOD
57	100	100	B-NP	CD	O	58	NMOD
58	%	%	I-NP	NN	O	53	PMOD
59	,	,	O	,	O	52	P
60	respectively	respectively	B-ADVP	RB	O	52	VMOD
61	,	,	O	,	O	47	P
62	for	for	B-PP	IN	O	47	NMOD
63	Illumigene	Illumigene	B-NP	NN	B-DNA	62	PMOD
64	against	against	B-PP	IN	O	63	NMOD
65	the	the	B-NP	DT	O	67	NMOD
66	reference	reference	I-NP	NN	O	67	NMOD
67	method	method	I-NP	NN	O	64	PMOD
68	.	.	O	.	O	21	P

1	A	A	B-NP	DT	O	2	NMOD
2	subset	subset	I-NP	NN	O	21	SUB
3	of	of	B-PP	IN	O	2	NMOD
4	27	27	B-NP	CD	O	5	NMOD
5	samples	sample	I-NP	NNS	O	3	PMOD
6	(	(	O	(	O	20	DEP
7	tcdB	tcdB	B-NP	NN	O	12	NMOD
8	(	(	O	(	O	10	DEP
9	+	+	B-NP	SYM	O	10	DEP
10	)	)	O	)	O	7	NMOD
11	,	,	O	,	O	12	P
12	n = 25	n = 25	B-NP	NN	B-protein	19	NMOD
13	;	;	O	:	O	19	P
14	tcdB	tcdB	B-NP	NN	O	19	NMOD
15	(	(	O	(	O	17	DEP
16	-	-	B-NP	SYM	O	17	DEP
17	)	)	O	)	O	14	NMOD
18	,	,	O	,	O	19	P
19	n= 2	n= 2	B-NP	NN	O	20	DEP
20	)	)	O	)	O	2	NMOD
21	were	be	B-VP	VBD	O	0	ROOT
22	further	further	I-VP	RBR	O	23	VMOD
23	compared	compare	I-VP	VBN	O	21	VC
24	between	between	B-PP	IN	O	23	VMOD
25	HE-LAMP-BART	HE-LAMP-BART	B-NP	NNP	O	27	NMOD
26	,	,	O	,	O	27	P
27	Illumigene	Illumigene	B-NP	NNP	O	29	NMOD
28	,	,	O	,	O	29	P
29	GeneXpert	GeneXpert	B-NP	NNP	O	46	NMOD
30	(	(	O	(	O	36	DEP
31	Cepheid	Cepheid	B-NP	NNP	O	33	NMOD
32	,	,	O	,	O	33	P
33	Sunnyvale	Sunnyvale	B-NP	NNP	O	35	NMOD
34	,	,	O	,	O	35	P
35	CA	CA	B-NP	NNP	O	36	DEP
36	)	)	O	)	O	29	NMOD
37	and	and	O	CC	O	46	NMOD
38	RIDA®QUICK	RIDA®QUICK	B-NP	NNP	O	46	NMOD
39	C.	C.	I-NP	NNP	O	46	NMOD
40	difficile	difficile	I-NP	NNP	O	46	NMOD
41	Toxin	Toxin	I-NP	NNP	O	46	NMOD
42	A/B	A/B	I-NP	NNP	O	46	NMOD
43	lateral	lateral	I-NP	JJ	O	46	NMOD
44	flow	flow	I-NP	NN	O	46	NMOD
45	rapid	rapid	I-NP	JJ	O	46	NMOD
46	test	test	I-NP	NN	O	24	PMOD
47	(	(	O	(	O	53	DEP
48	R-Biopharm	R-Biopharm	B-NP	NN	O	50	NMOD
49	,	,	O	,	O	50	P
50	Darmstadt	Darmstadt	B-NP	NNP	O	52	NMOD
51	,	,	O	,	O	52	P
52	Germany	Germany	B-NP	NNP	O	53	DEP
53	)	)	O	)	O	46	NMOD
54	resulting	result	B-VP	VBG	O	46	NMOD
55	in	in	B-PP	IN	O	54	VMOD
56	sensitivities	sensitivity	B-NP	NNS	O	55	PMOD
57	of	of	B-PP	IN	O	56	NMOD
58	HE-LAMP-BART	HE-LAMP-BART	B-NP	NN	O	60	NMOD
59	92	92	B-NP	CD	O	60	NMOD
60	%	%	I-NP	NN	O	69	NMOD
61	,	,	O	,	O	69	P
62	Illumigene	Illumigene	B-NP	NN	O	67	NMOD
63	72	72	I-NP	CD	O	67	NMOD
64	%	%	I-NP	NN	O	65	NMOD
65	GeneXpert	GeneXpert	I-NP	NN	O	67	NMOD
66	96	96	B-NP	CD	O	67	NMOD
67	%	%	I-NP	NN	O	69	NMOD
68	and	and	O	CC	O	69	NMOD
69	RIDAQuick	RIDAQuick	B-NP	NN	O	71	NMOD
70	76	76	B-NP	CD	O	71	NMOD
71	%	%	I-NP	NN	O	57	PMOD
72	against	against	B-PP	IN	O	71	NMOD
73	the	the	B-NP	DT	O	75	NMOD
74	reference	reference	I-NP	NN	O	75	NMOD
75	method	method	I-NP	NN	O	72	PMOD
76	.	.	O	.	O	21	P

1	The	The	B-NP	DT	O	3	NMOD
2	HE-LAMP-BART	HE-LAMP-BART	I-NP	NN	O	3	NMOD
3	method	method	I-NP	NN	O	4	SUB
4	offers	offer	B-VP	VBZ	O	0	ROOT
5	the	the	B-NP	DT	O	6	NMOD
6	advantages	advantage	I-NP	NNS	O	4	OBJ
7	of	of	B-PP	IN	O	6	NMOD
8	molecular	molecular	B-NP	JJ	O	10	NMOD
9	based	based	I-NP	JJ	O	10	NMOD
10	approaches	approach	I-NP	NNS	O	7	PMOD
11	without	without	B-PP	IN	O	10	NMOD
12	the	the	B-NP	DT	O	15	NMOD
13	cost	cost	I-NP	NN	O	15	NMOD
14	and	and	I-NP	CC	O	15	NMOD
15	complexity	complexity	I-NP	NN	O	11	PMOD
16	usually	usually	B-VP	RB	O	17	VMOD
17	associated	associate	I-VP	VBN	O	15	NMOD
18	with	with	B-PP	IN	O	17	VMOD
19	molecular	molecular	B-NP	JJ	O	20	NMOD
20	tests	test	I-NP	NNS	O	18	PMOD
21	.	.	O	.	O	4	P

1	Further	Further	B-ADVP	RB	O	9	VMOD
2	,	,	O	,	O	9	P
3	the	the	B-NP	DT	O	8	NMOD
4	rapid	rapid	I-NP	JJ	O	5	NMOD
5	time-to-result	time-to-result	I-NP	NN	O	8	NMOD
6	and	and	O	CC	O	8	NMOD
7	simple	simple	B-NP	JJ	O	8	NMOD
8	protocol	protocol	I-NP	NN	O	9	SUB
9	means	mean	B-VP	VBZ	O	0	ROOT
10	the	the	B-NP	DT	O	11	NMOD
11	method	method	I-NP	NN	O	12	SUB
12	can	can	B-VP	MD	O	9	VMOD
13	be	be	I-VP	VB	O	12	VC
14	applied	apply	I-VP	VBN	O	13	VC
15	away	away	B-ADVP	RB	O	14	VMOD
16	from	from	B-PP	IN	O	14	VMOD
17	the	the	B-NP	DT	O	20	NMOD
18	centralized	centralize	I-NP	VBN	O	20	NMOD
19	laboratory	laboratory	I-NP	NN	O	20	NMOD
20	settings	setting	I-NP	NNS	O	16	PMOD
21	.	.	O	.	O	9	P

